Prevent Blindness to Host the 2024 ASPECT Patient Engagement and Advocacy Summit May 14-16 in Washington, D.C.

By Staff
Monday, May 13, 2024 12:27 AM WASHINGTON, D.C.—Prevent Blindness, a nonprofit eye health and safety organization, announced that it will host the ASPECT Patient Engagement and Advocacy Summit, May 14-16, 2024, at the Madison Hotel in Washington, D.C. The Summit will bring together ASPECT (Advocacy, Support, Perspective, Empowerment, Communication, and Training) Patient Engagement Program graduates and program sponsors. As part of the event, Prevent Blindness will also hold its 19th Annual Eyes on Capitol Hill legislative day, providing participants with the opportunity to meet elected officials and their staff to discuss public policy and federal funding requests, the announcement stated.

VSP Vision Partners With HUED to Provide Cultural Competency and Humility Training for Network Doctors

By Staff
Monday, May 13, 2024 12:24 AM RANCHO CORDOVA, Calif.—VSP Vision, an eye health company with a focus on delivering access to health-centric vision care, and HUED, a learning and development company that creates equitable and inclusive health care content, have announced a partnership to offer cultural competency and humility training at no cost for VSP network doctors. Optometrists who complete the training will receive a continuing education credit (CE), council on optometric practitioner education (COPE) accreditation, and placement on the HUED Directory of Increased Visibility as a culturally competent and humbled provider.

NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results

By Staff
Monday, May 13, 2024 12:21 AM EMERYVILLE, Calif.—NovaBay Pharmaceuticals, Inc., a developer of eyecare, skin care and wound care products, has reported its financial results for the three months ended March 31, 2024. Net product sales for the first quarter of 2024 were $2.6 million

KITS Eyecare Reports Record First Quarter 2024 Results

By Staff
Monday, May 13, 2024 12:18 AM VANCOUVER, British Columbia—KITS Eyecare Ltd., a leading vertically integrated eyecare provider, has reported its results for the first quarter ended March 31, 2024. Revenue increased by 26 percent to $34.8 million.

Clearside Biomedical Announces First Quarter 2024 Financial Results

By Staff
Monday, May 13, 2024 12:15 AM ALPHARETTA, Ga.—Clearside Biomedical, Inc., a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases, has reported financial results for the first quarter ended March 31, 2024.

Warby Parker Announces Strong First Quarter 2024 Results and Raises Full-Year Guidance

By Staff
Friday, May 10, 2024 12:27 AM NEW YORK—Warby Parker Inc. (NYSE: WRBY), has announced financial results for the first quarter ended March 31, 2024. Net revenue increased $28.0 million, or 16.3 percent, to $200.0 million, as compared with the prior-year period. The company also announced that average revenue per customer increased 9.6 percent year-over-year to $296 with increased active customer growth of 3.2 percent to 2.36 million.

Marcolin Reports Consolidation of License Portfolio, Growing Margins in First Quarter of 2024

By Staff
Friday, May 10, 2024 12:24 AM LONGARONE and MILAN, Italy—The board of directors of Marcolin approved the economic and financial results of the group as of March 31, 2024. In the first three months of 2024, Marcolin has continued to consolidate its performances, in line with the results registered in 2023, carrying out its growth path undertaken in recent years.

Topcon Partners With Microsoft to Deliver AI-Powered Health Care Solutions

By Staff
Friday, May 10, 2024 12:21 AM OAKLAND, N.J.—Topcon Healthcare Inc. (THI), a provider of medical devices and software solutions, has announced a partnership with Microsoft Corporation to deliver AI-powered "Healthcare from the Eye" solutions to improve health care access, cost and quality.

The Vision Council Supports National Eye Institute in Celebrating Healthy Vision Month in May

By Staff
Friday, May 10, 2024 12:18 AM ALEXANDRIA, Va.—The Vision Council, the leading trade association for the optical industry, has partnered with the National Eye Institute this May in celebrating Healthy Vision Month, according to an announcement from the association. The 2024 campaign, “Reframe Your Future," seeks to teach those living with a visual impairment about the importance of utilizing mental health services and vision rehabilitation to enhance their day-to-day lives. According to the U.S. Surgeon General, the U.S. is facing a loneliness and isolation epidemic.

Tarsus Pharmaceuticals Reports First Quarter 2024 Financial Results

By Staff
Friday, May 10, 2024 12:15 AM IRVINE, Calif.—Tarsus Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutic eyecare treatments, has announced financial results for the first quarter ended March 31, 2024.

National Vision Holdings, Inc. Reports First Quarter 2024 Financial Results

By Staff
Thursday, May 9, 2024 12:27 AM DULUTH, Ga.—National Vision Holdings, Inc. (NASDAQ: EYE), one of the largest optical retail companies in the U.S., reported its financial results for the first quarter ended March 30, 2024. Net revenue increased 4.2 percent to $542.5 million compared with the first quarter of 2023 and was primarily driven by growth from new store sales, higher revenue from the company’s AC Lens business, and the effect of unearned revenue compared with the prior-year period. Net revenue includes a 0.5 percent impact from the timing of unearned revenue in the current-year period compared with the prior-year period, according to an announcement from the company.

The National Average for Gross Revenue at ECP Locations Decreased for the Week of April 29–May 5, Jobson’s Latest Practice Performance Tracker Shows

By Staff
Thursday, May 9, 2024 12:24 AM NEW YORK—The national average for gross revenue at ECP locations decreased last week, April 29–May 5, when compared with the previous week at a rate of -1 index point. That places gross revenue at a level 3 index points above where it was at this point in time (Week 18) when compared with last year (2023), 10 points above the same period in 2022, 14 points above 2021, 93 points above 2020 (during COVID) and 23 points above 2019, according to Jobson’s most recent Practice Performance Tracker.

STAAR Surgical Reports Increased Sales for First Quarter of 2024

By Staff
Thursday, May 9, 2024 12:21 AM LAKE FOREST, Calif.—STAAR Surgical Company, a developer, manufacturer and marketer of the EVO family of implantable collamer lenses (EVO ICL) for myopia, astigmatism and presbyopia, has reported financial results for the first quarter ended March 29, 2024.

Carl Zeiss Meditec Closes First Six Months of Fiscal Year 2023/24 With Slight Decline in Revenue

By Staff
Thursday, May 9, 2024 12:18 AM JENA, Germany—Carl Zeiss Meditec AG reported revenue of approximately €947.2 million in the first six months of fiscal year 2023/24 compared with prior year's €974.5 million, a decrease in revenue of 2.8 percent.

Safilo Group Reports Positive Start to Year in Europe, Subdued Sports and Eyewear Contemporary Segments in North America

By Staff
Wednesday, May 8, 2024 12:27 AM PADUA—The board of directors of Safilo Group S.p.A. yesterday reviewed and approved Q1 2024 economic and financial key performance indicators, according to an announcement from the company. Angelo Trocchia, Safilo’s chief executive officer, said, “In a business environment which is still complex and uncertain, it was again a positive start to the year for our European business, supported by the brilliant growth of Carrera, which has made its debut in our main markets with a  brand new women's collection that is gathering excellent feedback, and David Beckham, which continued to register strong progress in the global premium segment. In North America, sales were affected by a subdued winter season for the sports business and a wholesale eyewear market that remained weak in the contemporary segment, while the direct-to-consumer channel of both Blenders and Smith continued to grow nicely.